 |
Schering-Plough is on an exciting transformational journey, and nowhere is this more evident than in our research and development (R&D) area.
Our cross-functional teams consist of Ph.D's, M.D.'s, scientists, researchers and colleagues in other functional areas in the company. Every day, we approach our work realizing that the odds of finding a medical breakthrough in biopharmaceuticals are long. And yet, our motivation comes from knowing that the compounds that do prove effective may help patients with diseases that have no current cures or for which there are inadequate treatments.
At Schering-Plough Research Institute, we are upgrading our talent, our processes and our systems. We are investing in technologies and in bringing in products from outside sources. We are also building a culture at Schering-Plough that is especially suited for the challenging work of pharmaceutical research. Our focus on collaborative, shared-accountability behaviors among all of our people is one of our greatest innovation assets.
Our company has clearly identified R&D as the pivotal driving force for Schering-Plough.s long-term strength. Our goal is to keep raising the bar of excellence for R&D at Schering-Plough, and we want to become the standard of excellence in our industry.
Thomas P. Koestler, Ph.D.
Executive Vice President and President,
Schering-Plough Research Institute
|
|
About Us
